ArticleFrontiers in oncology2024

Case report: a case of lung squamous cell carcinoma with a novel FGFR3-IER5L fusion mutation responding to anlotinib.

Xiaoting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.